Sonothrombolysis Promotes Improvement in Left Ventricular Wall Motion and Perfusion Scores after Acute Myocardial Infarction
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | TAVARES, Bruno G. | |
dc.contributor.author | AGUIAR, Miguel Osman | |
dc.contributor.author | TSUTSUI, Jeane | |
dc.contributor.author | OLIVEIRA, Mucio | |
dc.contributor.author | SOEIRO, Alexandre de Matos | |
dc.contributor.author | NICOLAU, Jose | |
dc.contributor.author | RIBEIRO, Henrique | |
dc.contributor.author | POCHIANG, Hsu | |
dc.contributor.author | SBANO, Joao | |
dc.contributor.author | ROCHITTE, Carlos Eduardo | |
dc.contributor.author | LOPES, Bernardo | |
dc.contributor.author | RAMIREZ, Jose | |
dc.contributor.author | KALIL FILHO, Roberto | |
dc.contributor.author | MATHIAS, Wilson | |
dc.date.accessioned | 2022-08-12T17:05:48Z | |
dc.date.available | 2022-08-12T17:05:48Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background: It has recently been demonstrated that the application of high-energy ultrasound and microbubbles, in a technique known as sonothrombolysis, dissolves intravascular thrombi and increases the angiographic recanalization rate in patients with ST-segment-elevation myocardial infarction (STEMI). Objective: To evaluate the effects of sonothrombolysis on left ventricular wall motion and myocardial perfusion in patients with STEMI, using real-time myocardial perfusion echocardiography (RTMPE). Methods: One hundred patients with STEMI were randomized into the following 2 groups: therapy (50 patients treated with sonothrombolysis and primary coronary angioplasty) and control (50 patients treated with primary coronary angioplasty). The patients underwent RTMPE for analysis of left ventricular ejection fraction (LVEF), wall motion score index (WMSI), and number of segments with myocardial perfusion defects 72 hours after STEMI and at 6 months of follow-up. P < 0.05 was considered statistically significant. Results: Patients treated with sonothrombolysis had higher LVEF than the control group at 72 hours (50% +/- 10% versus 44% +/- 10%; p = 0.006), and this difference was maintained at 6 months of follow-up (53% +/- 10% versus 48% +/- 12%; p = 0.008). The WMSI was similar in the therapy and control groups at 72 hours (1.62 +/- 0.39 versus 1.75 +/- 0.40; p = 0.09), but it was lower in the therapy group at 6 months (1.46 +/- 0.36 versus 1.64 +/- 0.44; p = 0.02). The number of segments with perfusion defects on RTMPE was similar in therapy and control group at 72 hours (5.92 +/- 3.47 versus 6.94 +/- 3.39; p = 0.15), but it was lower in the therapy group at 6 months (4.64 +/- 3.31 versus 6.57 +/- 4.29; p = 0.01). Conclusion: Sonothrombolysis in patients with STEMI resulted in improved wall motion and ventricular perfusion scores over time. | eng |
dc.description.abstract | Fundamento: Demonstrou-se recentemente que a aplicação de ultrassom de alta energia com microbolhas, técnica conhecida como sonotrombólise, causa a dissolução de trombos intravasculares e aumenta a taxa de recanalização angiográfica no infarto agudo do miocárdio com supradesnivelamento do segmento ST (IAM-CSST). Objetivo: Avaliar o efeito da sonotrombólise nos índices de motilidade e perfusão miocárdicas em pacientes com IAM-CSST, utilizando a ecocardiografia com perfusão miocárdica em tempo real (EPMTR). Método: Uma centena de pacientes com IAM-CSST foram randomizados em dois grupos: Terapia (50 pacientes tratados com sonotrombólise e angioplastia coronária primária) e Controle (50 pacientes tratados com angioplastia coronária primária). Os pacientes realizaram EPMTR para analisar a fração de ejeção do ventrículo esquerdo (FEVE), o índice de escore de motilidade segmentar (IEMS) e o número de segmentos com defeito de perfusão miocárdica, 72 horas após o IAM-CSST e com 6 meses de acompanhamento. Foi considerado significativo p < 0,05. Resultados: Pacientes tratados com sonotrombólise apresentaram FEVE mais alta que o grupo Controle em 72 horas (50 ± 10% vs. 44 ± 10%; p = 0,006), e essa melhora foi mantida em seis meses (53 ± 10% vs. 48 ± 12%; p = 0,008). O IEMS foi similar nos grupos Terapia e Controle em 72 horas (1,62 ± 0,39 vs. 1,75 ± 0,40; p = 0,09), mas tornou-se menor no grupo Terapia em 6 meses (1,46 ± 0,36 vs. 1,64 ± 0,44; p = 0,02). O número de segmentos com defeito de perfusão não foi diferente entre os grupos em 72 horas (5,92 ± 3,47 vs. 6,94 ± 3,39; p = 0,15), mas ficou menor no grupo Terapia em 6 meses (4,64 ± 3,31 vs. 6,57 ± 4,29; p = 0,01). Conclusão: A sonotrombólise em pacientes com IAM-CSST resulta na melhora dos índices de motilidade e perfusão ventricular ao longo do tempo. | |
dc.description.index | MEDLINE | eng |
dc.identifier.citation | ARQUIVOS BRASILEIROS DE CARDIOLOGIA, v.118, n.4, p.756-765, 2022 | |
dc.identifier.doi | 10.36660/abc.20200651 | |
dc.identifier.issn | 0066-782X | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/48335 | |
dc.language.iso | por | |
dc.publisher | ARQUIVOS BRASILEIROS CARDIOLOGIA | eng |
dc.relation.ispartof | Arquivos Brasileiros de Cardiologia | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright ARQUIVOS BRASILEIROS CARDIOLOGIA | eng |
dc.subject | Myocardial Infarction | eng |
dc.subject | Sonothrombolysis | eng |
dc.subject | Microbubbles | eng |
dc.subject | Contrast Media | eng |
dc.subject | Ventricular Function Left | eng |
dc.subject | Pulmonary Embolism | eng |
dc.subject | Infarto do Miocárdio | |
dc.subject | Sonotrombólise | |
dc.subject | Microbolhas | |
dc.subject | Meios de Contraste | |
dc.subject | Função Ventricular Esquerda | |
dc.subject | Embolia Pulmonar | |
dc.subject.other | diagnostic ultrasound | eng |
dc.subject.other | transcutaneous ultrasound | eng |
dc.subject.other | cavitational mechanisms | eng |
dc.subject.other | american society | eng |
dc.subject.other | thrombolysis | eng |
dc.subject.other | coronary | eng |
dc.subject.other | echocardiography | eng |
dc.subject.other | microbubbles | eng |
dc.subject.other | heart | eng |
dc.subject.other | feasibility | eng |
dc.subject.wos | Cardiac & Cardiovascular Systems | eng |
dc.title | Sonothrombolysis Promotes Improvement in Left Ventricular Wall Motion and Perfusion Scores after Acute Myocardial Infarction | eng |
dc.title.alternative | A Sonotrombólise Promove Melhora dos Índices de Motilidade e Perfusão do Ventrículo Esquerdo após o Infarto Agudo do Miocárdio | |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.author.external | AGUIAR, Miguel Osman:Univ Sao Paulo, Fac Med, Hosp Clin, Inst Coracao, Rua Fidalga 618,Apt 84, BR-05303000 Sao Paulo, SP, Brazil | |
hcfmusp.author.external | LOPES, Bernardo:Univ Sao Paulo, Fac Med, Hosp Clin, Inst Coracao, Rua Fidalga 618,Apt 84, BR-05303000 Sao Paulo, SP, Brazil | |
hcfmusp.author.external | RAMIREZ, Jose:Univ Sao Paulo, Fac Med, Hosp Clin, Inst Coracao, Rua Fidalga 618,Apt 84, BR-05303000 Sao Paulo, SP, Brazil | |
hcfmusp.citation.scopus | 1 | |
hcfmusp.contributor.author-fmusphc | BRUNO GARCIA TAVARES | |
hcfmusp.contributor.author-fmusphc | JEANE MIKE TSUTSUI | |
hcfmusp.contributor.author-fmusphc | MUCIO TAVARES DE OLIVEIRA JUNIOR | |
hcfmusp.contributor.author-fmusphc | ALEXANDRE DE MATOS SOEIRO | |
hcfmusp.contributor.author-fmusphc | JOSE CARLOS NICOLAU | |
hcfmusp.contributor.author-fmusphc | HENRIQUE BARBOSA RIBEIRO | |
hcfmusp.contributor.author-fmusphc | HSU PO CHIANG | |
hcfmusp.contributor.author-fmusphc | JOAO CESAR NUNES SBANO | |
hcfmusp.contributor.author-fmusphc | CARLOS EDUARDO ROCHITTE | |
hcfmusp.contributor.author-fmusphc | ROBERTO KALIL FILHO | |
hcfmusp.contributor.author-fmusphc | WILSON MATHIAS JUNIOR | |
hcfmusp.description.beginpage | 756 | |
hcfmusp.description.endpage | 765 | |
hcfmusp.description.issue | 4 | |
hcfmusp.description.volume | 118 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 35508053 | |
hcfmusp.origem.scielo | SCIELO:S0066-782X2022000400756 | |
hcfmusp.origem.scopus | 2-s2.0-85129384147 | |
hcfmusp.origem.wos | WOS:000813888900019 | |
hcfmusp.publisher.city | RIO DE JANEIRO | eng |
hcfmusp.publisher.country | BRAZIL | eng |
hcfmusp.relation.reference | Aguiar MOD, 2020, CIRC-CARDIOVASC IMAG, V13, DOI 10.1161/CIRCIMAGING.119.009536 | eng |
hcfmusp.relation.reference | Aldrighi JM, 2015, ECHOCARDIOGR-J CARD, V32, P1277, DOI 10.1111/echo.12849 | eng |
hcfmusp.relation.reference | [Anonymous], 1988, LANCET, V2, P349 | eng |
hcfmusp.relation.reference | Birnbaum Y, 1998, CIRCULATION, V97, P130, DOI 10.1161/01.CIR.97.2.130 | eng |
hcfmusp.relation.reference | Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539 | eng |
hcfmusp.relation.reference | Cesar LA, 2014, ARQ BRAS CARDIOL, V103, P1, DOI 10.5935/abc.2014S004 | eng |
hcfmusp.relation.reference | Chen ZQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210516 | eng |
hcfmusp.relation.reference | Everbach EC, 2000, ULTRASOUND MED BIOL, V26, P1153, DOI 10.1016/S0301-5629(00)00250-7 | eng |
hcfmusp.relation.reference | Fine NM, 2021, J AM SOC ECHOCARDIOG, V34, P503, DOI 10.1016/j.echo.2020.12.009 | eng |
hcfmusp.relation.reference | Hudson M, 2010, JACC-CARDIOVASC INTE, V3, P352, DOI 10.1016/j.jcin.2009.11.020 | eng |
hcfmusp.relation.reference | Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003 | eng |
hcfmusp.relation.reference | Mathias W, 2019, J AM COLL CARDIOL, V73, P2832, DOI 10.1016/j.jacc.2019.03.006 | eng |
hcfmusp.relation.reference | Mathias Wilson Jr, 2019, CASE (Phila), V3, P14, DOI 10.1016/j.case.2018.11.006 | eng |
hcfmusp.relation.reference | Mathias W, 2016, J AM COLL CARDIOL, V67, P2506, DOI 10.1016/j.jacc.2016.03.542 | eng |
hcfmusp.relation.reference | Mattoso AAA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172280 | eng |
hcfmusp.relation.reference | O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1016/j.jacc.2012.11.018, 10.1161/CIR.0b013e3182742c84] | eng |
hcfmusp.relation.reference | Piegas LS, 2015, ARQ BRAS CARDIOL, V105, P1, DOI 10.5935/abc.20150107 | eng |
hcfmusp.relation.reference | Porter TR, 2018, J AM SOC ECHOCARDIOG, V31, P241, DOI 10.1016/j.echo.2017.11.013 | eng |
hcfmusp.relation.reference | Prokop AF, 2007, ULTRASOUND MED BIOL, V33, P924, DOI 10.1016/j.ultrasmedbio.2006.11.022 | eng |
hcfmusp.relation.reference | Qian LJ, 2020, ECHO RES PRACT, V7, P19, DOI 10.1530/ERP-20-0023 | eng |
hcfmusp.relation.reference | Rosenschein U, 1997, CIRCULATION, V95, P1411 | eng |
hcfmusp.relation.reference | Siegel RJ, 2004, J AM COLL CARDIOL, V44, P1454, DOI 10.1016/j.jacc.2004.06.062 | eng |
hcfmusp.relation.reference | Siegel RJ, 2001, ECHOCARDIOGR-J CARD, V18, P247, DOI 10.1046/j.1540-8175.2001.00247.x | eng |
hcfmusp.relation.reference | Slikkerveer J, 2012, ULTRASOUND MED BIOL, V38, P247, DOI 10.1016/j.ultrasmedbio.2011.11.001 | eng |
hcfmusp.relation.reference | Suchkova VN, 2000, CIRCULATION, V101, P2296, DOI 10.1161/01.CIR.101.19.2296 | eng |
hcfmusp.relation.reference | Uenishi EK, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0018-3 | eng |
hcfmusp.relation.reference | World Healthy Organization. (WHO), 2021, BRAZIL NCD 2018 WHO | eng |
hcfmusp.relation.reference | Xie F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069780 | eng |
hcfmusp.relation.reference | Xie F, 2011, J AM SOC ECHOCARDIOG, V24, P1400, DOI 10.1016/j.echo.2011.09.007 | eng |
hcfmusp.relation.reference | Xie F, 2009, JACC-CARDIOVASC IMAG, V2, P511, DOI 10.1016/j.jcmg.2009.02.002 | eng |
hcfmusp.relation.reference | Xie F, 2009, CIRCULATION, V119, P1378, DOI 10.1161/CIRCULATIONAHA.108.825067 | eng |
hcfmusp.relation.reference | ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002 | eng |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | 9d4173db-0c7f-421e-9c07-8b2ba4443db4 | |
relation.isAuthorOfPublication | 04583bbd-68cb-41dc-9c96-33c36a88f68f | |
relation.isAuthorOfPublication | 36634b98-5fa9-4c7f-b37f-ecd63f5fede5 | |
relation.isAuthorOfPublication | 477d0bf7-6f3f-4966-82f9-c7367c989a9b | |
relation.isAuthorOfPublication | 2ff39bf2-b5fb-4568-a932-b466563074d8 | |
relation.isAuthorOfPublication | 2fee1ac1-2e9a-43c1-bef1-d8ac78e3b1b1 | |
relation.isAuthorOfPublication | 6de33a17-042e-4e87-8e1e-f00118d014dd | |
relation.isAuthorOfPublication | 9f95b519-5f41-4046-be23-8cf2dc25bdd8 | |
relation.isAuthorOfPublication | e2e8fbd4-e06d-4a3f-a0e9-76a4650e56f2 | |
relation.isAuthorOfPublication | c934e4bf-7bb3-4e4d-aaac-07d8be41a3ac | |
relation.isAuthorOfPublication | 8c19f86f-f048-41b0-93fe-b246aac59043 | |
relation.isAuthorOfPublication.latestForDiscovery | 9d4173db-0c7f-421e-9c07-8b2ba4443db4 |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_TAVARES_Sonothrombolysis_Promotes_Improvement_in_Left_Ventricular_Wall_Motion_2022.PDF
- Tamanho:
- 508.25 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (Portuguese)